AU Patent

AU2017307306B2 — Intranasal pharmaceutical powder compositions

Assigned to Shin Nippon Biomedical Laboratories Ltd · Expires 2022-06-30 · 4y expired

What this patent protects

Disclosed herein are pharmaceutical powder compositions, methods of making such compositions, and uses thereof.

USPTO Abstract

Disclosed herein are pharmaceutical powder compositions, methods of making such compositions, and uses thereof.

Drugs covered by this patent

dihydroergotamine-mesylate (DIHYDROERGOTAMINE MESYLATE)

Patent Metadata

Patent number: AU2017307306B2
Jurisdiction: AU
Classification: —
Expires: 2022-06-30
Drug substance claim: No
Drug product claim: No
Assignee: Shin Nippon Biomedical Laboratories Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.